Transactions

  • Sort Order

  • Transactions Per Page

  • Reset

October, 2023

TenX Keane Acquisition Corp. (Nasdaq: TENK)

Acquisition of Citius Oncology, Inc. – A Wholly-owned Subsidiary of Citius Pharmaceuticals, Inc. (Nasdaq CTXR)

Fairness Opinion